Centers for Medicare and Medicaid Services Coverage of Amyloid PET.
作者信息
Grill Joshua D, Lingler Jennifer H
机构信息
Institute for Memory Impairments and Neurological Disorders, Departments of Psychiatry and Human Behavior and Neurobiology and Behavior, University of California, Irvine.
Department of Health and Community Systems, University of Pittsburgh School of Nursing, University of Pittsburgh Alzheimer's Disease Research Center, UPMC Montefiore, Pittsburgh, Pennsylvania.
出版信息
JAMA Neurol. 2024 Sep 1;81(9):903-904. doi: 10.1001/jamaneurol.2024.2100.
PMID:39008283
Abstract
摘要
相似文献
1
Centers for Medicare and Medicaid Services Coverage of Amyloid PET.医疗保险和医疗补助服务中心对淀粉样蛋白PET的覆盖范围。
JAMA Neurol. 2024 Sep 1;81(9):903-904. doi: 10.1001/jamaneurol.2024.2100.
2
Medicare and Amyloid PET Imaging: The Battle Over Evidence.医疗保险与淀粉样蛋白正电子发射断层显像：证据之争
J Aging Soc Policy. 2017 Mar-Apr;29(2):105-122. doi: 10.1080/08959420.2016.1198970. Epub 2016 Jun 10.
3
Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent.限制氟代硼替吡的使用：医疗保险对诊断和药物的覆盖标准不一致。
BMJ. 2015 Jul 3;351:h3333. doi: 10.1136/bmj.h3333.
4
Medicare to cover brain scans.医疗保险将涵盖脑部扫描。
Provider. 2005 Jan;31(1):41-2.
5
It's a zoo out there... we're doing PET scans.外面就像个动物园……我们正在做正电子发射断层扫描。
Radiol Manage. 2014 May-Jun;36(3):42-4.
6
The times they are a-changin'.时代在变。
Radiol Manage. 2009 May-Jun;31(3):16-8.
7
Test limits meet resistance: CMS seeks to restrict new PET scans for Alzheimer's.检测限制遭遇阻力：医疗保险和医疗补助服务中心试图限制针对阿尔茨海默病的新型正电子发射断层扫描（PET）检查。
Mod Healthc. 2013 Jul 8;43(27):4.
8
Medicare Coverage of Aducanumab - Implications for State Budgets.阿杜卡奴单抗的医疗保险覆盖范围——对州预算的影响。
N Engl J Med. 2021 Nov 25;385(22):2019-2021. doi: 10.1056/NEJMp2115297. Epub 2021 Nov 20.
9
ASNC model coverage policy: Cardiac positron emission tomographic imaging.美国核医学与分子影像学会（ASNC）模型覆盖政策：心脏正电子发射断层显像
J Nucl Cardiol. 2013 Oct;20(5):916-47. doi: 10.1007/s12350-013-9754-7.
10
CMS issues new instructions on PET coverage.医疗保险和医疗补助服务中心发布了关于正电子发射断层扫描（PET）保险范围的新指令。
J Nucl Med. 2014 Apr;55(4):9N-10N.
引用本文的文献
1
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.阿尔茨海默病淀粉样蛋白PET和脑脊液生物标志物临床应用的考量
Alzheimers Dement. 2025 Mar;21(3):e14528. doi: 10.1002/alz.14528.
2
Caregivers' Perspectives on Discussions of Medical Treatment Preferences for People Living With Dementia Are Associated With Their Dementia Health Literacy and the Caregiving Relationship.照顾者对痴呆症患者医疗治疗偏好讨论的看法与其痴呆症健康素养及照顾关系相关。
Gerontologist. 2025 Mar 25;65(4). doi: 10.1093/geront/gnaf033.
3
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions.医疗保险行政承包商区域内β淀粉样蛋白正电子发射断层扫描的使用情况
JAMA Neurol. 2025 Jan 1;82(1):108-109. doi: 10.1001/jamaneurol.2024.4073.
Zotero 插件